The Health Cyberinfrastructure (CI) Division of the San Diego Supercomputer Center (SDSC) at the University of California San Diego has partnered with the University of Rhode Island (URI) to provide an environment to protect a variety of data for researchers and PIs across the URI campus.
Researchers from University of California San Diego School of Medicine, with statewide collaborators, report that patients who recorded videos of themselves taking tuberculosis (TB) medications better adhered to treatment than patients who were observed in-person.
A consortium of nine University of California (UC), including UC San Diego, and 15 California State University (CSU) campuses recently received a five-year, $5 million grant from the National Science Foundation to dramatically increase diversity in physics and astronomy through the Cal-Bridge program. Launched four years ago, Cal-Bridge creates a pathway for underrepresented minority (URM) students from multiple CSU campuses to attend PhD programs in physics and astronomy at UCs across the state. The new NSF grant allows Cal-Bridge to expand from about a dozen URM scholars per year, to as many as 50 statewide, who will benefit from substantial financial support, research opportunities and various workshops.
The University of California San Diego was awarded $10.5 million over five years from the National Nuclear Security Administration (NNSA) to create one of four new centers of excellence. The Center for Matters under Extreme Pressure (CMEC) will be the third NNSA center focused on high energy density science.
Lucila Ohno-Machado, MD, PhD, chair of the Department of Biomedical Informatics at UC San Diego Health, professor of medicine and associate dean for informatics and technology at the School of Medicine, and a founding faculty member of UC San Diego Halicioğlu Data Science Institute, has been elected to the National Academy of Medicine (NAM).
Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although effective for her, are highly toxic. Tamara enrolled in a first-of-its-kind, pilot study at Moores Cancer Center at UC San Diego Health to test a personalized vaccine using her unique cancer mutations to boost an anti-tumor immune response.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
